FDA
approval
· 2024-08-28
FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Baxter Healthcare Corporation)
Summary
FDA approved Baxter Healthcare Corporation's supplemental application for naloxone hydrochloride, a generic opioid overdose reversal agent, under the approved A…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)